Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Regeneron Pharmaceuticals (REGN) Q4 2021 Earnings
REGN
+2.02%
4
Nov
Confirmed
Q1 2021
Q2 2021
Q3 2021
Q4 2021
8.47
14.25
20.02
25.8
Details
Expected EPS
10.8
Actual EPS
14.37
Surprise EPS
3.57
Surprise Percent
+33.06%
Description
Regeneron Pharmaceuticals (REGN) has reported earnings of 14.37 per share for Q4 2021.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login